NSE/IPCALAB (NSE/IPCALAB)

National Stock Exchange of India: NSE/IPCALAB · INR

₹1,927

-53.88 (-2.7%)· Recorded snapshot

Market cap	489.8B
Revenue (ttm)	101.3B
Net income (ttm)	13.1B
EPS (ttm)	₹51.6
Shares out	253.7M
P/E (trailing)	37.3x
P/E (forward)	30.8x
Dividend	₹6.00 (0.31%)
Volume	175,500
Beta	0.04

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 101.3B
Net income (ttm): 13.1B
EPS (ttm): ₹51.6
P/E (trailing): 37.3x
P/E (forward): 30.8x
Market cap: 489.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E30.8

P25 n/aP50 n/aP75 n/a

Trailing P/E37.3

P25 n/aP50 n/aP75 n/a

ROE13.2

P25 n/aP50 n/aP75 n/a

ROIC15.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NSE/IPCALAB indicators

Market & fundamental data

Available fields

256

Groups with data

Currency

INR

Showing 256 of 256 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-06
Employees	17,210
Employees change	432
Employees growth	2.57%
Enterprise value	INR 500.5B
Exchange	National Stock Exchange of India
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1949
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	INE571A01038
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2022-01-10
Last stock split type	Forward
Market cap	INR 489.8B
Next earnings date	2026-11-06
Price	INR 1,927.00
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	nse/IPCALAB
Website	https://www.ipca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	35.96x
Average P/E ratio (10Y)	34.51x
Average P/E ratio (3Y)	47.3x
Average P/E ratio (5Y)	42.58x
Earnings yield	2.68%
EV/Earnings	38.21x
EV/EBIT	26.87x
EV/EBITDA	21.99x
EV/FCF	102.98x
EV/Sales	4.94x
FCF / EV yield	0.97%
FCF yield	0.99%
Forward P/E	30.84x
Graham number	607.63973
Graham upside	-68.47%
Industry forward P/E	33.04x
Industry P/E	38.96x
Lynch fair value	INR 285.74
Lynch upside	-85.17%
P/(FCF - SBC) ratio	100.94x
P/(OCF - SBC) ratio	42.92x
P/B ratio	5.14x
P/E ratio	37.32x
P/FCF ratio	100.77x
P/OCF ratio	42.89x
P/S ratio	4.84x
PEG ratio	1.4x
Price / tangible book value	6.23x
Price/EBITDA ratio	21.72x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.44%
EBITDA margin	22.27%
Effective tax rate	24%
FCF margin	5.04%
Gross margin	67.73%
Operating margin	18.44%
Pretax margin	17.87%
Profit margin	12.93%
Profit per employee	INR 761,069
Profitable quarters	33
Profitable years	22
Revenue per employee	INR 5.9M
ROA	8.42%
ROA (5Y)	7.36%
ROCE	16.15%
ROE	13.22%
ROE (5Y)	11.27%
ROIC	15.53%
ROIC (5Y)	12.19%
SBC / revenue	0.01%
Tax / revenue	4.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.25%
EPS growth (Q)	72.36%
EPS growth (QoQ)	34.35%
EPS growth 10Y	25.3%
EPS growth 3Y	38.68%
EPS growth 5Y	5.51%
EPS growth quarters	9
EPS growth years	3
FCF growth	-10.95%
FCF growth 3Y	16%
FCF growth 5Y	-7.78%
Gross profit growth	13.79%
Gross profit growth (Q)	23.09%
Gross profit growth 3Y	21.86%
Gross profit growth 5Y	14.79%
Net income growth	68.21%
Net income growth (Q)	72.33%
Net income growth (QoQ)	34.38%
Net income growth 3Y	38.68%
Net income growth 5Y	5.53%
Net income growth quarters	9
Net income growth years	3
OCF growth	-13.57%
OCF growth 3Y	12.32%
OCF growth 5Y	0.93%
Operating income growth	35.55%
Operating income growth (Q)	76.6%
Operating income growth 3Y	36.51%
Operating income growth 5Y	10.41%
Revenue growth	10.58%
Revenue growth (Q)	20.76%
Revenue growth (QoQ)	16.69%
Revenue growth 10Y	25.26%
Revenue growth 3Y	17.45%
Revenue growth 5Y	13.18%
Revenue growth quarters	29
Revenue growth years	10

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -6.6B
Depreciation and amortization	INR 3.9B
EBIT	INR 18.7B
EBITDA	INR 22.6B
EPS	INR 51.63
FCF per share	INR 19.16
Financing cash flow	INR -7.5B
Free cash flow	INR 4.9B
Free cash flow minus SBC	INR 4.9B
Gross profit	INR 68.6B
Income taxes	INR 4.3B
Investing cash flow	INR -2.5B
Net borrowing	INR -6.2B
Net cash flow	INR 1.4B
Net income	INR 13.1B
Operating cash flow minus SBC	INR 11.4B
Operating income	INR 18.7B
Revenue	INR 101.3B
Stock-based compensation	INR 8.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 317.84
Debt / EBITDA	0.35
Debt / equity	0.08
Debt / FCF	1.66
Interest coverage	27.03
Net cash (debt)	INR 3.9B
Net cash / market cap	0.79%
Net debt / EBITDA	-0.17
Net debt / equity	-0.04
Net debt / FCF	-0.8
Piotroski F-Score	6
Shareholders' equity	INR 95.2B
Tangible book value	INR 78.7B
Tangible book value per share	INR 310.06
Total cash	INR 12B
Total debt	INR 8.1B
WACC	4.48%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.8
Current ratio	2.76
Inventory turnover	1.2
Quick ratio	1.48
Working capital	INR 40.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.02%
Dividend growth	50%
Dividend growth (10Y)	28.21%
Dividend growth (3Y)	44.22%
Dividend growth (5Y)	8.45%
Dividend growth years	0
Dividend payment date	2026-09-10
Dividend payment years	10
Dividend payout frequency	Annual
Dividend per share	INR 6.00
Dividend yield	0.31%
Ex-dividend date	2026-08-07
FCF payout ratio	31.32%
Last dividend	INR 6.00
Payout ratio	11.62%
Shareholder yield	0.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	523.52%
10Y return CAGR	20.47%
10Y total return	543.82%
150-day SMA	INR 1,731.54
15Y price change	1,478.22%
15Y return CAGR	20.65%
15Y total return	1,571.74%
1D price change	-2.72%
1M price change	-2.22%
1M total return	-2.22%
1W price change	6.2%
1W total return	6.2%
1Y price change	48.46%
1Y return CAGR	49.02%
1Y total return	48.98%
20-day SMA	INR 1,920.70
200-day SMA	INR 1,671.07
20Y price change	4,269.12%
20Y return CAGR	21.6%
20Y total return	4,895.66%
3M price change	8.41%
3M total return	8.78%
3Y price change	96.03%
3Y return CAGR	25.55%
3Y total return	97.91%
50-day SMA	INR 1,939.80
50-day SMA vs 200-day SMA	50over200
52-week high	INR 2,038.00
52-week high date	2026-09-18
52-week low	INR 1,268.00
52-week low date	2025-10-31
5Y price change	77.41%
5Y return CAGR	12.56%
5Y total return	80.64%
6M price change	25.02%
6M total return	25.46%
All-time high	INR 2,038.00
All-time high date	2026-09-18
All-time low	INR 5.50
All-time low date	2001-09-17
Average true range (ATR)	INR 68.18
Average volume	252.1K
Beta (1Y)	-0.05
Beta (2Y)	0.05
Beta (5Y)	0.04
Change from 52-week high	-5.45%
Change from 52-week low	51.97%
Change from all-time high	-5.45%
Change from all-time low	34,936.36%
Change from open	-2.68%
Day's gap	-0.04%
Dollar volume	INR 338.2M
High price	INR 1,988.50
Low price	INR 1,921.00
Monthly RSI	68.88
Open price	INR 1,980.00
Position in 52-week range	8.89%
Previous close	INR 1,980.80
Price vs 150-day SMA	11.29%
Price vs 20-day SMA	0.33%
Price vs 200-day SMA	15.32%
Price vs 50-day SMA	-0.66%
Relative volume	0.71
RSI	50.76
Sharpe ratio	1.39
Sharpe ratio (3Y)	0.8
Sharpe ratio (5Y)	0.36
Sortino ratio	2.7
Sortino ratio (3Y)	1.47
Sortino ratio (5Y)	0.76
Volume	175.5K
Weekly RSI	59.65
YTD price change	35.81%
YTD total return	36.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	139.3M
Shares change (QoQ)	0.02%
Shares change (YoY)	-0.02%
Shares held by insiders	7.13%
Shares held by institutions	52.65%
Shares outstanding	253.7M

Deeper analysis on NSE/IPCALAB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NSE/IPCALAB report

Is a complete NSE/IPCALAB research report available?

No complete published report is available for nse/IPCALAB (NSE/IPCALAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/IPCALAB (NSE/IPCALAB)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/IPCALAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/IPCALAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NSE/IPCALAB

Frequently asked questions